Daniel Weisdorf, MD
Enriched profileProfessor Emeritus, Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School · University of Minnesota Medical School
Daniel Weisdorf is Professor Emeritus, Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School at University of Minnesota Medical School. OpenAlex indexes 1,288 publications with 76,789 citations (h-index 126); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology / Oncology profiles in the findmyKOL directory. Clarivate lists Daniel Weisdorf as a Highly Cited Researcher (Cross-Field, 2022-2023).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Daniel Weisdorf, MD, is Professor Emeritus, Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School. The public record shows 1,288 publications with 76,789 citations (h-index 126), centered on Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 3 companies, 10 NIH-funded awards (1997–2026).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Hematopoietic Stem Cell Transplantation
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 61 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 607.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Selecting a Favorable KIR Donor in Unrelated HCT for AML
Sponsor: Masonic Cancer Center, University of Minnesota
- Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Sponsor: Masonic Cancer Center, University of Minnesota
- Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Sponsor: Masonic Cancer Center, University of Minnesota
Industry payments
Updated 27 Aug 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20251 payment
- National Marrow Donor ProgramProgram year20231 payment
- Incyte CorporationProgram year20223 payments
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor100%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
10 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:
- University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
University of Minnesota
FY2026$7,652,142UM1TR004405
Congress activity
Updated 27 Aug 2026
87 congress contributions (2004–2025) across ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Clonal Hematopoiesis and Venous Thromboembolism Risk in Lymphoma Patients Surviving Autologous Transplantation
ASH Annual Meeting
ASH2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.
Journal of clinical oncology
Clinical Trial2026 - Smoking cessation among blood or marrow transplant Survivors: a BMTSS Report.
Bone marrow transplantation
Letter2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Acute Myeloid Leukemia3,383 citations2015
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/daniel-weisdorf-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Daniel-Weisdorf-43829004
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
astct.org/Nucleus/Article/titans-of-transplant-dr-daniel-weisdorf
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →astct.org ↗ - Spotify
creators.spotify.com/pod/profile/astct/episodes/Titans-of-Transplant-Dr--Daniel-Weisdorf-e34npu8
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →creators.spotify.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Board Certified
Hematology and Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- Former Principal Investigator and Steering Committee Chair
NIH Blood and Marrow Transplantation Clinical Trials Network
2016verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Cross-Field20222023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- 2020 Charles Bolles Bolles-Rogers Award (Twin Cities Medical Society Foundation)
outstanding physician award for professional contribution to medical research, achievement or leadership
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinicalaffairs.umn.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.umn.edu ↗
Secondary affiliations
appointments beyond the home institution- Deputy Director
University of Minnesota Clinical and Translational Science Institute (CTSI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ctsi.umn.edu ↗
Media & interviews
press, podcasts and appearances- "Titans of Transplant: Dr. Daniel Weisdorf"
ASTCT video interview series (with Dr. Shernan Holtan), published June 2025, on the evolution of cellular therapy and transplantation
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →astct.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Miller, MD
University of Minnesota Medical School
Emmanuel Antonarakis, MD
University of Minnesota Medical School
David Boulware, MD, MPH
University of Minnesota Medical School
Jerrold Vitek, MD
University of Minnesota Medical School